Jim Chanos Negative Again on Valeant Pharma (VRX) in CNBC Interview

October 25, 2016 12:41 PM EDT

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Jim Chanos is discussing Valeant Pharma (NYSE: VRX) negative again on CNBC. Says uneconomical to shareholders.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Hedge Funds, Short Sales, Trader Talk

Related Entities

Jim Chanos

Add Your Comment